cdmo.directory
← Compare landing

WuXi Advanced Therapies vs Maravai LifeSciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/advancedtherapies/maravai

CategoryWuXi Advanced TherapiesMaravai LifeSciences
Listed sitecdmocdmo
SummaryCell & gene therapy CDMO offering discovery, process development, analytical development, cell banking, clinical and commercial manufacturing, plus biosafety testing for biologics, mAbs, vaccines, and CGT developers.Leading provider of nucleic acid products, custom enzymes, and bioprocess analytics supporting vaccine, therapeutic, and diagnostic development from discovery through commercialization, with mRNA CDMO services including proprietary CleanCap® capping technology.
Services
  • Cell Therapy Manufacturing
  • Autologous Cell Therapy Manufacturing
  • Allogeneic Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Cell-Line Development
  • Technology Transfer
  • Process Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Quality Control Testing
  • Vaccine Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Recombinant Protein Manufacturing
  • mRNA Manufacturing
  • Oligonucleotide Manufacturing
  • Vaccine Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Quality Control Testing
  • Process Development
  • Cell-Line Development
  • CMC Analytical Development
  • Stability Testing & Storage
  • Technology Transfer
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • Vaccine
  • AAV / Viral Vector Platform
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Oligonucleotide
  • mRNA
  • Gene Therapy
  • Vaccine
IndicationsData not yet provided.
  • Oncology
  • Neurology
  • Cardiovascular
  • Infectious Disease
  • Rare Disease
Locations
  • Headquarters, Philadelphia, PA, United States
  • Philadelphia, Philadelphia, PA, United States
  • Allendale, Allendale, NJ, United States
  • Taufkirchen, Taufkirchen, Bavaria, Germany
  • London, London, England, United Kingdom
  • Yokohama, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Philadelphia, PA, United States
  • Manufacturing, Allendale, NJ, United States
  • Manufacturing, Taufkirchen, Bavaria, Germany
  • Office, London, England, United Kingdom
  • Manufacturing, Yokohama, Kanagawa, Japan
  • Manufacturing & Testing, Allendale, NJ, United States
  • Manufacturing & Testing, Taufkirchen, Bavaria, Germany
  • Manufacturing & Testing, Yokohama, Kanagawa, Japan
Data not yet provided.
Certifications
  • FDA · Identifier: Commercial manufacturing approval
  • EMA · Identifier: Commercial manufacturing approval
  • PMDA · Identifier: Commercial manufacturing approval
  • FDA · Identifier: FDA approval for commercial manufacturing
  • EMA · Identifier: EMA approval for commercial manufacturing
  • PMDA · Identifier: PMDA approval for commercial manufacturing
  • ISO · Identifier: ISO-9001:2015
  • ISO · Identifier: ISO-9001:2015
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.